Effectiveness and Safety of Topical Finasteride and Minoxidil Combination Compared to Topical Minoxidil for The Treatment of Male Androgenetic Alopecia

Launched by INDONESIA UNIVERSITY · Aug 4, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness and safety of a combination treatment using topical finasteride and minoxidil compared to just minoxidil alone for men with male pattern baldness, also known as androgenetic alopecia. The trial involves 40 male participants aged between 18 and 59 years who have been diagnosed with this condition. To be eligible, participants should have a specific type of hair loss as defined by a scale used by doctors and must be willing to commit to the study requirements, such as not cutting or coloring their hair during the trial.

Participants in the study can expect to apply the topical treatments as directed and will be monitored for their progress. The study is currently recruiting volunteers, and it's important to note that some individuals may not be eligible if they have certain scalp conditions, are taking specific medications for hair growth, or have had recent hair treatments. This research aims to find better ways to help men dealing with hair loss, and those who join will contribute to important findings that could benefit others in the future.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • 1. Male aged from 18-59 years diagnosed with androgenic alopecia
• • 2. Androgenic alopecia type III-V according to Hamilton-Norwood criteria
• • 3. Willing to participate in this research by signing the consent form after receiving an explanation from the researcher
• • 4. Willing to not cutting the hair nor coloring the hair during the study
• Exclusion Criteria:
• • 1. Diagnosed with other infectious or inflammatory skin disease in the scalp
• • 2. Using oral medications or vitamins that aim to increase the amount of hair in the last 1 month
• • 3. Using topical medication that aim to increase the amount of hair in the last 2 weeks
• • 4. Undergoing cosmetic procedure for AGA therapy such as low-level laser therapy (LLLT) procedures, platelet-rich plasma (PRP) injections, or microneedling within the last 3 months
• • 5. Have sexual disorder such as decreased libido
• • 6. Have a history of allergy or irritant contact dermatitis to the minoxidil and finasteride